Samsung Biologics announced on the 18th that it participated in the 2025 BioProcess International (BPI), a global bio-industry conference. BPI is a world-renowned bio event where the latest ...
Samsung Biologics reaffirmed its global contract development and manufacturing organization (CDMO) leadership by operating a standalone booth for the first time at “BioJapan 2025” in Yokohama, Japan.
Samsung Biologics announced on October 10 that it had successfully concluded its participation in "Bio Japan 2025," Asia's largest pharmaceutical and bio exhibition, held in Yokohama, Japan, from ...
INCHEON, South Korea, Jan. 14, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its latest business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback